ACHV logo

ACHV
Achieve Life Sciences Inc.

16,235
Mkt Cap
$171.97M
Volume
504,864.00
52W High
$6.03
52W Low
$1.84
PE Ratio
-2.49
ACHV Fundamentals
Price
$3.23
Prev Close
$3.14
Open
$3.10
50D MA
$4.14
Beta
1.23
Avg. Volume
752,103.94
EPS (Annual)
-$1.25
P/B
7.99
Rev/Employee
$0.00
$195.22
Loading...
Loading...
News
all
press releases
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Average Rating of "Moderate Buy" from Brokerages
Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) have been assigned an average rating of "Moderate Buy" from the five analysts that are presently covering the firm...
MarketBeat·7d ago
News Placeholder
More News
News Placeholder
HC Wainwright Has Positive Estimate for ACHV FY2026 Earnings
Achieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) - Equities researchers at HC Wainwright boosted their FY2026 earnings estimates for shares of Achieve Life Sciences in a research report issued...
MarketBeat·10d ago
News Placeholder
What is Zacks Research's Estimate for ACHV FY2026 Earnings?
Achieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) - Zacks Research dropped their FY2026 earnings per share estimates for shares of Achieve Life Sciences in a note issued to investors on...
MarketBeat·10d ago
News Placeholder
Achieve Life Sciences Flags FDA Observations While Pushing Launch To 2027 For Smoking Cessation Med
Achieve Life Sciences taps Adare for cytisinicline manufacturing as stock falls; reports wider losses and shifts US launch timeline to 2027.read more...
Benzinga·11d ago
News Placeholder
Q1 Earnings Estimate for ACHV Issued By HC Wainwright
Achieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) - Stock analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for shares of Achieve Life Sciences in a research report...
MarketBeat·11d ago
News Placeholder
HC Wainwright Reiterates "Buy" Rating for Achieve Life Sciences (NASDAQ:ACHV)
HC Wainwright reaffirmed a "buy" rating and set a $12.00 price objective on shares of Achieve Life Sciences in a research report on Wednesday...
MarketBeat·12d ago
News Placeholder
Achieve Life Sciences Sees Unusually Large Options Volume (NASDAQ:ACHV)
Achieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) was the recipient of some unusual options trading on Tuesday. Stock investors acquired 2,079 call options on the company. This represents an increase of approximately 175% compared to the typical daily volume of 756 call options...
MarketBeat·13d ago
News Placeholder
Achieve Life Sciences Q4 Earnings Call Highlights
Achieve Life Sciences (NASDAQ:ACHV) used its fourth-quarter and full-year 2025 earnings call to outline progress toward a potential U.S. launch of cytisinicline, the company's investigational therapy...
MarketBeat·13d ago
News Placeholder
Achieve Life Sciences (NASDAQ:ACHV) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS
Achieve Life Sciences (NASDAQ:ACHV - Get Free Report) announced its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($0.28) EPS for the quarter, missing the consensus...
MarketBeat·13d ago
News Placeholder
Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200 Day Moving Average - Time to Sell?
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Crosses Above 200 Day Moving Average - Time to Sell...
MarketBeat·24d ago
<
1
2
...
>

Latest ACHV News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.